These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 11428990)
1. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease. Hsieh WS; Lemas MV; Ambinder RF Transpl Infect Dis; 1999 Sep; 1(3):204-12. PubMed ID: 11428990 [TBL] [Abstract][Full Text] [Related]
2. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate. Mentzer SJ; Perrine SP; Faller DV Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400 [TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Tanner JE; Alfieri C Transpl Infect Dis; 2001 Jun; 3(2):60-9. PubMed ID: 11395971 [TBL] [Abstract][Full Text] [Related]
4. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients. Colombini E; Guzzo I; Morolli F; Longo G; Russo C; Lombardi A; Merli P; Barzon L; Murer L; Piga S; Ciofi Degli Atti ML; Locatelli F; Dello Strologo L Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938 [TBL] [Abstract][Full Text] [Related]
5. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Dolcetti R Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317 [TBL] [Abstract][Full Text] [Related]
6. Lytic and latent EBV gene expression in transplant recipients with and without post-transplant lymphoproliferative disorder. Kroll J; Li S; Levi M; Weinberg A J Clin Virol; 2011 Nov; 52(3):231-5. PubMed ID: 21900040 [TBL] [Abstract][Full Text] [Related]
7. Evidence of Epstein-Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder. Zaffiri L; Frankel C; Bush EJ; Neely ML; Pavlisko EN; Mokrova IL; Luftig MA; Palmer SM J Med Virol; 2021 Aug; 93(8):5040-5047. PubMed ID: 33704812 [TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Allen UD; Preiksaitis JK; Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381 [TBL] [Abstract][Full Text] [Related]
9. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055 [TBL] [Abstract][Full Text] [Related]
10. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment. Petrara MR; Giunco S; Serraino D; Dolcetti R; De Rossi A Cancer Lett; 2015 Dec; 369(1):37-44. PubMed ID: 26279520 [TBL] [Abstract][Full Text] [Related]
11. Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. Comoli P; Labirio M; Basso S; Baldanti F; Grossi P; Furione M; ViganĂ² M; Fiocchi R; Rossi G; Ginevri F; Gridelli B; Moretta A; Montagna D; Locatelli F; Gerna G; Maccario R Blood; 2002 Apr; 99(7):2592-8. PubMed ID: 11895798 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. Sebelin-Wulf K; Nguyen TD; Oertel S; Papp-Vary M; Trappe RU; Schulzki A; Pezzutto A; Riess H; Subklewe M Transpl Immunol; 2007 Apr; 17(3):203-10. PubMed ID: 17331848 [TBL] [Abstract][Full Text] [Related]
14. The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Green M; Michaels MG; Webber SA; Rowe D; Reyes J Pediatr Transplant; 1999 Nov; 3(4):271-81. PubMed ID: 10562971 [TBL] [Abstract][Full Text] [Related]
15. Genomic variations in EBNA3C of EBV associate with posttransplant lymphoproliferative disorder. Maloney EM; Busque VA; Hui ST; Toh J; Fernandez-Vina M; Krams SM; Esquivel CO; Martinez OM JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32213705 [TBL] [Abstract][Full Text] [Related]
16. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder. Martinez OM; Krams SM Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031 [TBL] [Abstract][Full Text] [Related]
17. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling. Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379 [TBL] [Abstract][Full Text] [Related]
18. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study. Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725 [TBL] [Abstract][Full Text] [Related]
19. Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases. Kim N; Sohn HJ; Oh JH; Jeon YW; Lee HJ; Cho HI; Chung BH; Yang CW; Kim TG; Cho SG Int J Hematol; 2018 May; 107(5):596-603. PubMed ID: 29188583 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Paya CV; Fung JJ; Nalesnik MA; Kieff E; Green M; Gores G; Habermann TM; Wiesner PH; Swinnen JL; Woodle ES; Bromberg JS Transplantation; 1999 Nov; 68(10):1517-25. PubMed ID: 10589949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]